Please login to the form below

Not currently logged in

Amgen’s Biosimilar Trends Report shows benefit of competition from biosimilars

Amgen flag

Competition created by biosimilars has delivered $9.8bn in savings over five years and could reduce patients’ out-of-pocket costs by $238m

EU “still interested” in Valneva COVID vaccine despite UK snub

EU flagNegotiations between Valneva and the EU are “ongoing and advanced”, with its vaccine candidate VLA2001 touted as a potential booster shot in France

US orders 1.4 million more doses of Regeneron antibody cocktail

RegeneronThe new $2.9bn order increases the amount of Regeneron’s anti-COVID REGEN-COV purchased by the US government to nearly 3 million doses

Valneva shares fall as UK cancels COVID-19 vaccine order

LondonThe UK government has cancelled a supply agreement for French vaccine maker Valneva’s COVID candidate VLA2001 over an alleged breach of obligations.

AbbVie signs gene therapy deal in eye care

AbbVie buildingAbbVie and REGENXBIO have teamed up on RGX-314, a potential one-time gene therapy against two leading causes of blindness, wet AMD and diabetic retinopathy.

Roche expands infectious disease test portfolio

Roche Basel SwitzerlandPCR test specialist TIB Molbiol will join Roche to bolster its molecular diagnostics solutions for infectious diseases

Roche bets on T-cell therapies with Adaptimmune deal

Roche Basel SwitzerlandGenentech signs deal for five ‘off the shelf’ T-cell therapies and a personalised cell therapy platform in a deal potentially worth more than $3bn

PMGroup Worldwide Ltd and The Datateam Media Group welcome Samedan Ltd

PMGroup logo web Samedan joins PMGroup and PharmaTimes Media Ltd as part of The Datateam Media Group’s healthcare division

Pfizer to acquire Canadian immuno-oncology company Trillium in a deal worth $2.6bn

Pfizer new logo 2021The deal will strengthen Pfizer’s oncology offering and follows an investment of $25m in Trillium made by Pfizer in January

Business in the USAHealth coverage across state lines

Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad

  • Ho_Ung_KimStanding out in a crowd

    Celltrion Healthcare’s Ho-Ung Kim on pricing, market access and regulatory challenges for successfully developing biosimilars

  • HeadsThe diseased organisation

    Like humans, organisations can be afflicted by genetic disorders that hinder performance and threaten survival but these can be understood and cured

COVID-19 Updates and Daily News

Featured jobs


Add my company
Onyx Health Ltd

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...